A new study, with help from artificial intelligence, focuses on reprogramming cancer stem cells and triggering some to ‘self-destruct’ ...
Cellarity, a biotechnology company developing cell state-correcting therapies through integrated multi-omics and AI modeling, ...
A new computational tool developed by researchers has uncovered genetic evidence directly linking Alzheimer’s disease to the ...
This study offers a valuable methodological advance by introducing a gene panel selection approach that captures combinatorial specificity to define cell identity. The findings address key limitations ...
Scientists at University of California San Diego have developed a new approach to destroying cancer stem cells – hard-to-find cells that help cancers spread, come back after treatment and resist ...
The ability of immune cells—particularly CD8+ T cells—to launch a rapid burst of proliferation inside tumors is key to the ...
Study findings suggest using the drug PF-06409577 to restore CDX2 in colon cancers could cut risk of recurrence and death by up to 50%.
Scientists at University of California San Diego have developed a new approach to destroying cancer stem cells—hard-to-find ...
Murray Dines says his Topeka-based company, Go Bird Go, has created and is marketing the world’s first bird feeder to use ...
Scientists based in Australia and China have identified a pair of pesky enzymes responsible for prolonging prostate cancer – ...
Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. Cells change their metabolic profiles in ...
EMBL researchers created SDR-seq, a next-generation tool that decodes both DNA and RNA from the same cell. It finally opens ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results